Literature DB >> 16240220

The effect of Helicobacter pylori on insulin resistance.

Selim Aydemir1, Taner Bayraktaroglu, Mehmet Sert, Coskun Sokmen, Hulusi Atmaca, Gorkem Mungan, Banu Dogan Gun, Ali Borazan, Yucel Ustundag.   

Abstract

Helicobacter pylori causes a lifelong infection in the stomach after exposure. H. pylorihas been shown to be associated with peptic ulcer and gastric cancer development. Moreover, it is held responsible for some other nongastric diseases. Among them, coronary heart disease attracts much debate. Many studies have demonstrated a close relationship between insulin resistance and atherosclerosis. Chronic inflammation and alterations in counter-regulatory hormones are deemed responsible for the etiology of insulin resistance. We aimed to examine the effect of H. pylori on insulin resistance. Sixty-three patients were enrolled in the study. Patients were divided into two groups according to H. pylori presence. HOMA-IR (homeostasis model assessment of insulin resistance) level was used to assess insülin resistance. Thirty-six patients were H. pylori positive and 27 were H. pylori negative. There was no difference between the two groups with regard to age, gender, or body mass index. HOMA-IR level was 1.73+/- 1.1 in the H. pylori-negative group, whereas it was 2.56 +/- 1.54 in the H. pylori-positive group (P < 0.05). This study provides the first direct evidence for an association between chronic H. pylori infection and insulin resistance.

Entities:  

Mesh:

Year:  2005        PMID: 16240220     DOI: 10.1007/s10620-005-3012-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

Review 2.  Insulin resistance--mechanisms, syndromes, and implications.

Authors:  D E Moller; J S Flier
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

Review 3.  Insulin resistance and its treatment by thiazolidinediones.

Authors:  H E Lebovitz; M A Banerji
Journal:  Recent Prog Horm Res       Date:  2001

4.  Helicobacter pylori infection and insulin-dependent diabetes mellitus.

Authors:  D A de Luis; H de la Calle; G Roy; C M de Argila; S Valdezate; R Canton; D Boixeda
Journal:  Diabetes Res Clin Pract       Date:  1998-02       Impact factor: 5.602

5.  Helicobacter pylori infection and fasting plasma glucose concentration.

Authors:  H G Peach; N E Barnett
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

6.  Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

Authors:  C Weyer; P A Tataranni; C Bogardus; R E Pratley
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

7.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

8.  Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.

Authors:  T J Colturi; R H Unger; M Feldman
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  High seroprevalence of Helicobacter pylori in diabetes mellitus patients.

Authors:  B Oldenburg; R J Diepersloot; J B Hoekstra
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

Review 10.  Helicobacter pylori modulation of gastric acid.

Authors:  J Calam
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
View more
  36 in total

1.  Helicobacter pylori and insulin resistance: time to do interventional studies.

Authors:  Rinaldo Pellicano; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2009-09-30       Impact factor: 3.199

2.  H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program.

Authors:  Saud Alzahrani; Jason Nelson; Steven F Moss; Jessica K Paulus; William C Knowler; Anastassios G Pittas
Journal:  J Diabetes Complications       Date:  2017-06-03       Impact factor: 2.852

Review 3.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis.

Authors:  Rajesh Vijayvergiya; Ramalingam Vadivelu
Journal:  World J Cardiol       Date:  2015-03-26

Review 4.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 5.  Extraintestinal manifestations of Helicobacter pylori: a concise review.

Authors:  Frank Wong; Erin Rayner-Hartley; Michael F Byrne
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 6.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

7.  Histopathological Findings in Morbid Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: Does H. pylori Infection Effective on Pathological Changes?

Authors:  Ramazan İlyas Öner; Sabri Özdaş
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

8.  Exacerbation of chronic inflammatory diseases by infectious agents: Fact or fiction?

Authors:  Cheng-Ming Wang; Bernhard Kaltenboeck
Journal:  World J Diabetes       Date:  2010-05-15

Review 9.  Diabetes and gastric cancer: the potential links.

Authors:  Chin-Hsiao Tseng; Farn-Hsuan Tseng
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

10.  Potential effect of chronic Helicobacter pylori infection on glucose metabolism of Mongolian gerbils.

Authors:  Zhen Yang; Wei Li; Cong He; Chuan Xie; Yin Zhu; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.